•Phase 3 EPCORE DLBCL-4 trial showed epcoritamab combination reduced disease progression risk by up to 60% in relapsed/refractory DLBCL.
•Genmab announced positive Phase 3 results for epcoritamab plus lenalidomide demonstrating statistically significant improvement in progression-free survival.
•U.S. Senator Angus King urged the Federal Energy Regulatory Commission to reject NextEra Energy's proposed $66.8 billion acquisition of Dominion Energy.
•Crude oil stocks in the US Strategic Petroleum Reserve fell by 5.5 million barrels to 325.7 million barrels, the lowest level since May 1983, according to Department of Energy data.
•A Michigan judge issued a ruling on Monday blocking Kalshi from allowing residents to place financial bets on sporting events, after the state's attorney general accused it of violating gaming law.
•Iran's president calls Trump's comments 'unreasonable boasting and unfounded threats,' stating understanding is mutual if the US adheres to the MOU.
•Iranian and American negotiating teams both travel to Doha this week, but Tehran insists no direct talks are planned.
•Missile and drone exchanges occurred over the weekend, with the US bombing Iranian military facilities and Iran striking American sites in Kuwait and Bahrain.
•AeroVironment reported higher fourth-quarter profit as revenue more than doubled to $641.6 million from $275.1 million a year earlier, driven by higher product sales and service revenue.
•The New England Journal of Medicine retracted a pivotal clinical trial paper on Amgen's Tavneos drug after FDA findings of altered patient data and unblinding of some researchers.
•Lobbying efforts to kill a proposed ban on some defense contractors buying back their own stock in the National Defense Authorization Act for fiscal 2027 are heating up.
•British American Tobacco plans to cut 5,500 jobs and outsource 3,500 roles as part of an AI-driven restructuring amid declining traditional tobacco sales.
•OpenPayd announced the filing of a registration statement on Form F-4 with the SEC in connection with its proposed business combination with Titan Acquisition Corp. (TACH).
•The combined company is expected to become a Nasdaq-listed public company under the ticker 'OP' with an implied pro forma equity value exceeding $1 billion.
•Up to approximately $276 million in gross proceeds are available from Titan's trust account, assuming no redemptions by Titan's public shareholders.
•Australia's competition regulator has taken Amazon's Australian unit to court, alleging its Prime subscription contracts contained unfair terms that allowed advertising to be added to Prime Video.
•Digital Realty (DLR) announced a registered secondary offering of $2,346 million of its common stock by affiliates of Blackstone.
•The offering is conditioned upon the closing of Digital Realty's acquisition of Blackstone's interests in two joint ventures, expected to close on June 30, 2026.
•Corteva announced that Greg Page will chair the board of the future independent crop protection company upon its planned separation in Q4 2026.
•Corteva announced that Karen Grimes will chair the board of Vylor Inc., the future advanced seed and genetics company resulting from the planned separation in Q4 2026.
•Rosen Law Firm announced a class action lawsuit against Futu Holdings Limited (NASDAQ: FUTU) on behalf of purchasers of its securities between May 24, 2023 and May 27, 2026.
•American Coastal Insurance Corporation completed the repurchase of 1,365,980 shares for $14.4 million at an average price of $10.57 per share in Q2 2026.
•BMO Financial Group announced a definitive agreement to acquire the Australia-based capital markets business of Euroz Hartleys Group Limited (ASX:EZL).